• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Carter Ledyard & Milburn LLP

  • Professionals
  • Practices
  • Our Firm
  • Careers
  • News & Insights
  • Contact
Stay Connected
Stay Connected
Subscribe To Our Publications
PrintPDFEmail

Carter Ledyard Advises Client PainReform Ltd., an Israeli Biotechnology Company, in its Initial Public Offering on NASDAQ

September 3, 2020/less than a minute

Carter Ledyard client, PainReform Ltd., a clinical stage Israeli biotechnology company focused on the reformulation of established therapeutics, was advised by Carter Ledyard’s Steven J. Glusband and Guy Ben-Ami, together with Israeli firm Doron Tikotzky Kantor Gutman & Amit Gross, in its $20,000,000 initial public offering on September 1, 2020. PainReform’s proprietary extended release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates.

sidebar

Related Professionals

  • Steven Glusband Feature

    Steven J. Glusband

    /

    Partner

    D/212-238-8605
    glusband@clm.com
  • Guy Ben-Ami Feature

    Guy Ben-Ami

    /

    Counsel

    D/212-238-8658
    benami@clm.com
Copyright Carter Ledyard & Milburn LLPPowered by Content Pilot
  • Sitemap
  • Disclaimer
  • Cookie Policy
  • Privacy Policy

Meritas

Meritas.org Logo

Legal Link

Legal link dot org logo